CTI BioPharma to Present at the JMP Securities Hematology & Oncology Summit on Monday, December 6
Event: JMP Securities Hematology & Oncology Summit
Date: Monday, December 6, 2021
The presentation will be webcast live and available for replay from the Investors section of
About CTI BioPharma Corp.
We are a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies for blood-related cancers that offer a unique benefit to patients and their healthcare providers. We concentrate our efforts on treatments that target blood-related cancers where there is an unmet medical need. In particular, we are focused on developing and commercializing pacritinib, our product candidate currently in active late-stage development. We are headquartered in
CTI BioPharma Investor Contacts:
View original content to download multimedia:https://www.prnewswire.com/news-releases/cti-biopharma-to-present-at-the-jmp-securities-hematology--oncology-summit-on-monday-december-6-301436710.html